Shahab Asgharzadeh

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Topics

Diffuse Large B Cell Lymphoma

Palliative Care

Acute Lymphoblastic Leukemia

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal for immunotherapy of cancer

Cancer immunology, immunotherapy : CII

Pharmaceutical statistics

This page only lists publications with an associated author ORCID identifier.

Publications

Liron D Grossmann, Chia-Hui Chen, Yasin Uzun, Anusha Thadi, Adam J Wolpaw, Kevin Louault, Yael Goldstein, Lea F Surrey, Daniel Martinez, Matteo Calafatti, Mark Gerelus, Peng Gao, Lobin Lee, Khushbu Patel, Rebecca S Kaufman, Guy Shani, Alvin Farrel, Sharon Moshitch-Moshkovitz, Paris Grimaldi, Matthew Shapiro, Nathan M Kendsersky, Jarrett M Lindsay, Colleen E Casey, Kateryna Krytska, Laura Scolaro, Matthew Tsang, David Groff, Smita Matkar, Josh R Kalna, Emily Mycek, Jayne McDevitt, Erin Runbeck, Tasleema Patel, Kathrin Maria Bernt, Shahab Asgharzadeh, Yves A DeClerck, Yael P Mosse, Kai Tan, John M Maris
Identification and characterization of chemotherapy resistant high-risk neuroblastoma persister cells. Cancer discovery (2024)
Amy K Erbe, Mitch B Diccianni, Rajen Mody, Arlene Naranjo, Fan F Zhang, Jen Birstler, KyungMann Kim, Arika S Feils, Jung-Tung Hung, Wendy B London, Barry L Shulkin, Varsha Mathew, Marguerite T Parisi, Sabah Servaes, Shahab Asgharzadeh, John M Maris, Julie Park, Alice Lin-Tsing Yu, Paul M Sondel, Rochelle Bagatell
KIR/KIR-ligand genotypes and clinical outcomes following chemoimmunotherapy in patients with relapsed or refractory neuroblastoma: a report from the Children's Oncology Group. Journal for immunotherapy of cancer 11 (2) (2023)
Navin R Pinto, Arlene Naranjo, Xiangming Ding, Fan F Zhang, Emily Hibbitts, Rebekah Kennedy, Rachelle Tibbetts, Shannon Wong-Michalak, David W Craig, Zarko Manojlovic, Michael D Hogarty, Susan Kreissman, Rochelle Bagatell, Meredith S Irwin, Julie R Park, Shahab Asgharzadeh
Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology without MYCN Amplification. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Amy K Erbe, Mitch B Diccianni, Rajen Mody, Arlene Naranjo, Fan F Zhang, Jen Birstler, KyungMann Kim, Arika S Feils, Jung-Tung Hung, Wendy B London, Barry L Shulkin, Varsha Mathew, Marguerite T Parisi, Sabah Servaes, Shahab Asgharzadeh, John M Maris, Julie Park, Alice Lin-Tsing Yu, Paul M Sondel, Rochelle Bagatell
KIR/KIR-ligand genotypes and clinical outcomes following chemoimmunotherapy in patients with relapsed or refractory neuroblastoma: a report from the Children's Oncology Group. Journal for immunotherapy of cancer 11 (2) (2023)
Amy K Erbe, Mitch B Diccianni, Rajen Mody, Arlene Naranjo, Fan F Zhang, Jen Birstler, KyungMann Kim, Arika S Feils, Jung-Tung Hung, Wendy B London, Barry L Shulkin, Varsha Mathew, Marguerite T Parisi, Sabah Servaes, Shahab Asgharzadeh, John M Maris, Julie Park, Alice Lin-Tsing Yu, Paul M Sondel, Rochelle Bagatell
KIR/KIR-ligand genotypes and clinical outcomes following chemoimmunotherapy in patients with relapsed or refractory neuroblastoma: a report from the Children's Oncology Group. Journal for immunotherapy of cancer 11 (2) (2023)
Navin R Pinto, Arlene Naranjo, Xiangming Ding, Fan F Zhang, Emily Hibbitts, Rebekah Kennedy, Rachelle Tibbetts, Shannon Wong-Michalak, David W Craig, Zarko Manojlovic, Michael D Hogarty, Susan Kreissman, Rochelle Bagatell, Meredith S Irwin, Julie R Park, Shahab Asgharzadeh
Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology without MYCN Amplification. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Navin R Pinto, Arlene Naranjo, Xiangming Ding, Fan F Zhang, Emily Hibbitts, Rebekah Kennedy, Rachelle Tibbetts, Shannon Wong-Michalak, David W Craig, Zarko Manojlovic, Michael D Hogarty, Susan Kreissman, Rochelle Bagatell, Meredith S Irwin, Julie R Park, Shahab Asgharzadeh
Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology without MYCN Amplification. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Meredith S Irwin, Arlene Naranjo, Fan F Zhang, Susan L Cohn, Wendy B London, Julie M Gastier-Foster, Nilsa C Ramirez, Ruthann Pfau, Shalini Reshmi, Elizabeth Wagner, Jed Nuchtern, Shahab Asgharzadeh, Hiroyuki Shimada, John M Maris, Rochelle Bagatell, Julie R Park, Michael D Hogarty
Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (29) (2021)
Rachelle Tibbetts, Kee Kiat Yeo, Sakunthala Muthugounder, Meng-Hua Lee, Cham Jung, Tania Porras-Corredor, Michael A Sheard, Shahab Asgharzadeh
Anti-disialoganglioside antibody internalization by neuroblastoma cells as a mechanism of immunotherapy resistance. Cancer immunology, immunotherapy : CII (2021)
Yong-Dong Wang, Diana Merino Vega, Nicholas Light, Brian L Murphy, Xiaohui Guo, Andrew P Hodges, Lianne Q Chau, Kun-Wei Liu, Girish Dhall, Shahab Asgharzadeh, Erin N Kiehna, Ryan J Shirey, Kim D Janda, Michael D Taylor, David Malkin, David W Ellison, Scott R VandenBerg, Charles G Eberhart, Rosalie C Sears, Martine F Roussel, Richard J Gilbertson, Robert J Wechsler-Reya
Myc and Loss of p53 Cooperate to Drive Formation of Choroid Plexus Carcinoma. Cancer research 79 (9) (2019)
Lingyun Ji, Juan Pablo Lewinger, Mark Krailo, Susan Groshen, David V Conti, Shahab Asgharzadeh, Richard Sposto
Improvements to the Escalation with Overdose Control design and a comparison with the restricted Continual Reassessment Method. Pharmaceutical statistics 18 (6) (2019)